Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 12 for Mayo Nephrology Collaborative Group

Edit search filters
  1. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression

    Jacksonville, FL, Rochester, MN

  2. Rituximab in Progressive IgA Nephropathy

    Rochester, MN

  3. Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

    Rochester, MN

  4. Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis

    Rochester, MN

  5. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS

    Rochester, MN

  6. MEmbranous Nephropathy Trial Of Rituximab

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy

    Rochester, MN

  8. Open-label Trial of Daratumumab in Treatment of PGNIMD and C3 GN

    Rochester, MN, Jacksonville, FL

  9. A Registry and Biospecimen Collection to Advance the Diagnosis and Care of Patients with Glomerular Diseases

    Rochester, MN

  10. Nephrotic Syndrome Study Network

    Rochester, MN


Mayo Clinic Footer